Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. August 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

NEWTOWN, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
04. August 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022

NEWTOWN, Pa., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
13. Juni 2022 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Key Management Promotions

Mark Guerin promoted to Chief Operating Officer and Chief Financial Officer Dr. Adar Makovski Silverstein promoted to Senior Director and Head of Corporate Development NEWTOWN, Pa., June 13, 2022 ...
26. Mai 2022 17:10 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Abstract at the ASCO Annual Meeting Highlighting Narazaciclib’s Differentiated Inhibitory and Improved Safety Profile in Preclinical Models

NEWTOWN, Pa., May 26, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
11. Mai 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

NEWTOWN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
04. Mai 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce First Quarter Financial Results on May 11, 2022

NEWTOWN, Pa., May 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
27. April 2022 10:17 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Acceptance of Abstract for Publication at the ASCO Annual Meeting

NEWTOWN, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
23. März 2022 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit

NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
17. März 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Full Year 2021 Financial Results and Provides Business Update

NEWTOWN, Pa., March 17, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
10. März 2022 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022

NEWTOWN, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...

Vorherige Seite

Nächste Seite